Harbour Investments’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$52.9K Sell
272
-17
-6% -$3.52K ﹤0.01% 2371
2026
Q1
$64.9K Buy
289
+59
+26% +$14.7K ﹤0.01% 2195
2025
Q4
$55.4K Sell
230
-18
-7% -$4.6K ﹤0.01% 1919
2025
Q3
$67.9K Buy
248
+4
+2% +$1.09K ﹤0.01% 1758
2025
Q2
$63K Buy
244
+177
+264% +$42.2K ﹤0.01% 1705
2025
Q1
$15K Buy
67
+16
+31% +$3.73K ﹤0.01% 2323
2024
Q4
$11.7K Sell
51
-1
-2% -$241 ﹤0.01% 2377
2024
Q3
$12.7K Sell
52
-3
-5% -$670 ﹤0.01% 2249
2024
Q2
$10.5K Buy
55
+17
+45% +$3.45K ﹤0.01% 2243
2024
Q1
$7.53K Buy
38
+6
+19% +$1.1K ﹤0.01% 2331
2023
Q4
$5.5K Buy
32
+20
+167% +$3.07K ﹤0.01% 2376
2023
Q3
$1.77K Buy
12
+6
+100% +$1.08K ﹤0.01% 2582
2023
Q2
$1.31K Sell
6
-94
-94% -$21K ﹤0.01% 2641
2023
Q1
$21.9K Hold
100
﹤0.01% 1704
2022
Q4
$20.8K Sell
100
-2
-2% -$439 ﹤0.01% 1660
2022
Q3
$21K Hold
102
﹤0.01% 1629
2022
Q2
$21K Buy
+102
New +$21.7K ﹤0.01% 1629
2021
Q4
$26K Sell
100
-50
-33% -$13K ﹤0.01% 1558
2021
Q3
$40K Hold
150
﹤0.01% 1912
2021
Q2
$37K Hold
150
﹤0.01% 1981
2021
Q1
$29K Buy
+150
New +$30.1K ﹤0.01% 1993

Other funds holding RMD

Harbour Investments's RMD Position: Q2 2026 in Review

Harbour Investments reduced its ResMed (RMD) stake by 5.9% in Q2 2026, selling an estimated $3.52K and leaving 272 shares worth $52.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2371.

Harbour Investments first reported a position in RMD in Q1 2021 and has held it in 21 quarters since. The position peaked at $67.9K in Q3 2025. 882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Harbour Investments held 272 shares of ResMed worth $52.9K as of Q2 2026.
  • Harbour Investments sold 17 ResMed shares in Q2 2026, an estimated $3.52K.
  • ResMed made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #2371 holding.
  • Harbour Investments first reported a position in ResMed in Q1 2021 and has held it in 21 quarters since.
  • Harbour Investments's ResMed position peaked at $67.9K in Q3 2025.
  • 882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.